We now know more about genes than ever before and this increased understanding provides scientists with an unparalleled opportunity to study and understand diseases. Thanks to the mapping of the human genome, clinical practice is shifting from treatment based on symptoms to treatment based on each person's unique genetic make-up—in other words, personalized medicine.

Translational research is the process of translating basic scientific discoveries into clinical applications such as new diagnostics and treatments. Translational research serves as a bridge between lab bench discoveries and the patient bedside. Information collected at the patient bedside can circle back to the laboratory to fuel additional discoveries.

Translational research provides the data and tools necessary to identify the genes that play a role in hereditable diseases and understand the genetic changes contributing to disease progression and resistance to therapy. Through partnering relationships with academic, clinical, and corporate entities, TGen's mission is to deliver these discoveries to the patient bedside as improved healthcare interventions. TGen's layered, multidisciplinary approach combines a solid infrastructure with scientific technologies and programs, academic and corporate partnerships, and enterprise efforts.

At TGen, investigators are pushing the limits of cutting-edge research and technology to discover the genetic cause of disease. Experiments that were impossible and impractical only a few years ago are now conducted every day.

Discovery fuels TGen's translational research and lies at the heart of our scientific investigations. TGen's research divisions are designed to foster a wide range of genetic discoveries. These divisions draw heavily upon TGen's scientific platforms to expedite findings. TGen's labs are staffed by teams of researchers focused on making genomic discoveries in common diseases and disorders in the areas of oncology, neurogenomics and metabolic disease.